The longterm goal of my research is to develop prevention and therapeutic approaches to reduce, augment, enhance, or replace the use of antibiotics. My approach to achieve the goal is to study the microbe and host interactions as well as the mechanisms enabling the microorganisms to be resistant to the actions of antibiotics. Understanding of these interactions and resistance mechanisms will enable us to develop effective disease prevention and treatment methods. Under this vision, my team has 1) developed nanoparticles that display multivalent bacterial adhesin-specific receptors, mimicking host cell surface, to facilitate their bindings to targeted bacteria; 2) functionalized iron-oxide nanoparticles with adhesin-specific receptors to study the feasibility of using such magnetic nanoparticles for hyperthermic inactivation of targeted microorganisms; 3) developed biosensors for rapid and sensitive detection of targeted pathogens; 4) developed antimicrobial peptides that are target-specific to control the growth of foodborne pathogens and to minimize the emergence of antibiotic resistant bacteria; 5) identified nutraceutical compounds that exhibit antimicrobial activities but with low host toxicities; 6) purified bacterial efflux pump inhibitors from nutraceuticals to facilitate the effective treatment of multidrug-resistant pathogens; 7) developed modified surfaces, e.g., catheters, surgical pins and plates, that minimize bacterial infections and/or prevent bacterial attachment (biofilm formation).

